Special Issue Title:

Treatment of Advanced Gynecological Malignancies

Deadline for manuscript submissions: 31 December 2022

Print Special Issue Flyer (14)

Special Issue Editor

  • Guest Editor

    Jinhui Liu, PhDE-MailWebsite

    Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, China

    Interests: Basic and clinical research on gynecological tumors

Special Issue Information

Dear Colleagues,


Gynecological malignancies occur in the female reproductive system, including ovarian cancer, cervical cancer, and endometrial cancer. These cancers severely impact the health of women and greatly increase the global cancer burden. Consequently, there is an urgent need to develop new therapeutic agents and treatment strategies that are effective against these cancers.


Traditional treatments are less effective for advanced/recurrent gynecological malignancies. With the continuous development of precise tumor treatment, the existing medical methods and drug treatment will gradually improve the limitations and deficiencies of the previous treatment mode. Targeted therapy and immunotherapy have become a research hotspot in recent years. It even brings the possibility of cure to some patients who had no hope of treatment. However, PD-1/PD-L1 inhibitors are ineffective for most patients with advanced/recurrent gynecological tumors, or the duration of efficacy is short, which has become a bottleneck for immunotherapy. In order to improve the therapeutic effect, it has become a new trend to use it in combination with other drugs; In the other hand, finding more effective molecular markers will divert patients who may be effective in immunotherapy, which has important clinical significance. In addition, the evaluation and treatment of PD-1/PD-L1 inhibitor-related adverse events have also received much attention.


This issue is devoted to the research on the molecular mechanism of immunotherapy resistance, reversing the state of immune resistance, and even finding new therapeutic targets.


Jinhui Liu, PhD

Guest Editor

Keywords

Advanced; Cervical Cancer; Ovarian Cancer; Endometrial Cancer; Immunotherapy; Resistance; Targeted Therapy

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences